Improving Patient Outcomes Begins with Reflex Testing

Targeted Genetics Meets Enhanced Adherence Monitoring

Gain Insight


Making The Right Call Just Got Easier. Let Pharmacogenetics Guide Your Treatment.

achieve RESPONSE™


Transition To A Better Lab Solution.

explore SWIFT™


Solutions That Allow Providers To Do What They Do Best – Focus On Patients.

Our Solutions

Substance Abuse Research Alliance

LabSolutions is proud to be a member of SARA, a program of the Georgia Prevention Project.

Learn More

Secure Provider Portal

Our intuitive portal allows you to access results and request consults from anywhere.


Bi-Directional EMR Interfaces

Less time maintaining charts and requisitioning orders means more time with your patients.

Experienced Staff

Direct access to our scientists allows your team to leverage years of experience.


On-Site Specimen Collection Services

Placement of a qualified LabSolutions specimen collector saves your staff valuable time.

Flexible Reporting Preferences

Customizable patient reports delivered when and where you want them.

Eligibility and Utilization Training

The use of conservative testing protocols that focus on necessity ensures providers are ordering responsibly.

100,000 Deaths

According to the FDA, 100,000 people die each year from adverse drug reactions. Acknowledging the impact pharmacogenomics can have on this death toll, the FDA now lists known genetic factors on packages of 137 of its approved medications.

1,200,000 ED Visits

According to the National Institute on Drug Abuse, 1.2 million emergency visits per year involve the non-medical use of pharmaceuticals. The most frequently reported drugs were opiate/opioid analgesics, present in 50 percent of the non-medical-use ED visits.

$3.5 Billion in Costs

According to the CDC, adverse drug reactions cost the U.S. health system approximately $3.5 billion annually. The potential cost-savings of pharmacogenomic testing is a huge opportunity in healthcare today which could dramatically improve the quality and standard of care.



Reflex confirmations for drugs of abuse; perfect for treatment/abuse facilities.


A comprehensive Hereditary Cancer Risk Assessment tool to uncover patient’s genetic predisposition.


A game-changing test designed to identify the right medication for the right patient.


Carrier screening allows each patient to identify how their personal genetic makeup may affect future family planning.


Non-invasive Prenatal Testing is designed to detect chromosomal abnormalities, with minimal risk to mom and baby.



Wellness testing empowers both the patient and their physician with accurate data to navigate their road to better health.

We Can Help

Personalized approaches to healthcare that incorporate screening and monitoring tools result in improved patient outcomes and long term cost lowering. Let our team design a custom solution for you today.

Contact Us